In early 2023, we visualised our Psychedelics Drug Development Tracker data in a ‘bullseye chart’ format as part of 2022’s Year in Review. Due to its popularity, Noah Smith and Michael Haichin have once again prepared a bullseye chart of the psychedelic drug development pipeline, as it stood at the end of 2023.
Given the number of candidates included, we recommend downloading a PDF of the tracker for a better viewing experience. More info below the image.